Lanmar

This Biotech stock is likely to be a HUGE winner this year

做多
Lanmar 已更新   
NASDAQ:BIOS   None
A minimum expected target is 60% ROI ($6 per share). A multi-bagger is definitely in the cards as it historically returned several x from its previous bottoms in 2000 and 2008/2009.
评论:
Bullish structure still intact ... earnings release in two days. Technical structure continues to suggest major upside is more likely.

评论:
Major rally since yesterday

评论:
Massive failed breakout. I got lucky to get out at a small lose just under my average cost of 3.25. Situations like these should constantly remind us why risk management is so crucial to success as a trader.
交易结束:到达止损:
loss*
交易开始:
Re-entered at 3.85 and added at 4.15. The key with this trade from here is it coming to fruition quickly.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。